Notes - Semi-Annual Consolidated Statement Of Comprehensive Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7601173

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Notes - Semi-annual consolidated statement of comprehensive income
Notes - Semi-annual consolidated single statement of comprehensive income
Major components of selling, general and administrative expenses
Notes regarding impairment losses
Notes regarding gain on sale of property, plant and equipment

※5.固定資産売却益

 当社子会社の旧西東京事業所の跡地の売却によるものであります。

Talk to a Data Expert

Have a question? We'll get back to you promptly.